questionText: To ask the Secretary of State for Health and Social Care, what steps his department has taken to make the drug Enhertu available for people with secondary breast cancer in England, following the increase in NICE’s cost effectiveness thresholds in April 2026.
answerText: Following the increase in the National Institute for Health and Care Excellence’s (NICE) cost-effectiveness thresholds in April 2026, NICE, NHS England, and the manufacturers have resumed discussions to explore whether a commercial offer can be agreed tha...
heading: Breast Cancer: Drugs